The success or failure of radiation therapy rests, in part, on selective killing of tumor cells over normal cells. It is poorly known which molecular mechanisms are responsible for this difference. The applicants will test the overall hypothesis that adhesion to physiological extracellular matrices provides positional survival signals to epithelial normal cells that are reduced or absent in tumor cells. It is further hypothesized that tumor cells counteract loss of matrix-dependent survival signals through inappropriate activation of growth factor receptors. In support of these hypotheses, preliminary evidence revealed that certain matrix components, including the basement membrane type IV collagen, enhance radioresistance of malignant keratinocytes when the epidermal growth factor receptor (EGFR) is blocked. The overall goal of this application is to further define molecular mechanisms and pathways by which integrin engagement and EGFR activation coordinately control epithelial cell survival. This will be done using normal keratinocytes and cells representing an early stage of keratinocyte tumor progression (HaCaT).
The Specific Aims of the work proposed are to (1) define matrix components and cognate matrix adhesion receptors that contribute to radiation resistance in these cells, (2) characterize coordinate control of signaling pathways (PI-3- kinase/AKT; MEK/MAPK) that contribute to cell survival by integrin engagement and EGFR activation, (3) assess functional roles of integrins and the EGFR in survival of HaCaT cells grown as tumor cell nests in organotypic epidermal reconstructs. Epidermal reconstructs represent a uniquely versatile three-dimensional tissue model to assess complex regulation of cell survival. To assess functional roles of specific surface receptors and signaling molecules in HaCaT cell survival the investigators have established a tetracycline regulatable gene expression system in these cells allowing the conditional expression of antisense and dominant negative constructs even if they are lethal in 2D cell culture. The use of these tools in organotypic reconstructs promises to provide novel information about cell survival signaling in an 'in vivo' context with clear implications for therapeutic intervention.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA106633-02
Application #
6862614
Study Section
Radiation Therapeutics and Biology Study Section (RTB)
Program Officer
Stone, Helen B
Project Start
2004-04-01
Project End
2008-03-31
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
2
Fiscal Year
2005
Total Cost
$257,480
Indirect Cost
Name
Thomas Jefferson University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Ohri, Nitin; Dicker, Adam P; Lawrence, Yaacov Richard (2012) Can drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro data. Int J Radiat Oncol Biol Phys 83:385-93
Daroczi, Borbala; Kari, Gabor; Ren, Qing et al. (2009) Nuclear factor kappaB inhibitors alleviate and the proteasome inhibitor PS-341 exacerbates radiation toxicity in zebrafish embryos. Mol Cancer Ther 8:2625-34
Chung, Christine H; Wong, Stuart; Ang, K Kian et al. (2007) Strategic plans to promote head and neck cancer translational research within the radiation therapy oncology group: a report from the translational research program. Int J Radiat Oncol Biol Phys 69:S67-78
Chung, Christine H; Parker, Joel; Levy, Shawn et al. (2007) Gene expression profiles as markers of aggressive disease-EGFR as a factor. Int J Radiat Oncol Biol Phys 69:S102-5
Khor, Li-Yan; Bae, Kyounghwa; Pollack, Alan et al. (2007) COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial. Lancet Oncol 8:912-20
Gaffney, David K; Winter, Kathryn; Dicker, Adam P et al. (2007) Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128. Int J Radiat Oncol Biol Phys 69:111-7
Gaffney, David K; Winter, Kathryn; Dicker, Adam P et al. (2007) A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128. Int J Radiat Oncol Biol Phys 67:104-9
Kari, G; Rodeck, U; Dicker, A P (2007) Zebrafish: an emerging model system for human disease and drug discovery. Clin Pharmacol Ther 82:70-80
Wachsberger, Phyllis R; Burd, Randy; Cardi, Chris et al. (2007) VEGF trap in combination with radiotherapy improves tumor control in u87 glioblastoma. Int J Radiat Oncol Biol Phys 67:1526-37
Daroczi, Borbala; Kari, Gabor; McAleer, Mary Frances et al. (2006) In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafish model. Clin Cancer Res 12:7086-91

Showing the most recent 10 out of 17 publications